{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:14:47Z","timestamp":1761808487945,"version":"3.40.5"},"reference-count":34,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T00:00:00Z","timestamp":1637971200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.1080\/14740338.2022.2007882","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T15:53:59Z","timestamp":1637164439000},"page":"295-302","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Safety evaluation of the DTaP5-IPV-Hib-HepB vaccine: a review"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-5385","authenticated-orcid":false,"given":"Francesca","family":"Fortunato","sequence":"first","affiliation":[{"name":"Policlinico Riuniti Foggia Hospital, Hygiene Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-3167","authenticated-orcid":false,"given":"Domenico","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Policlinico Riuniti Foggia Hospital, Hygiene Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-8054","authenticated-orcid":false,"given":"Pier Luigi","family":"Lopalco","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8138-5835","authenticated-orcid":false,"given":"Rosa","family":"Prato","sequence":"additional","affiliation":[{"name":"Policlinico Riuniti Foggia Hospital, Hygiene Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,11,27]]},"reference":[{"issue":"3","key":"cit0001","first-page":"E424","volume":"61","author":"Icardi G","year":"2020","journal-title":"J Prev Med Hyg"},{"key":"cit0002","unstructured":"European Medicines Agency. Infanrix hexa \u2013 EPAR: product information [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2020 Oct 15; cited 2021 Jun 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/infanrix-hexa-epar-product-information_en.pdf"},{"key":"cit0003","unstructured":"European Medicines Agency. Hexyon \u2013 EPAR: product information [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2021 Mar 25; cited 2021 Jun 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/hexyon-epar-product-information_en.pdf"},{"key":"cit0004","unstructured":"European Medicines Agency. Vaxelis \u2013 EPAR: product information [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2020 Dec 1; cited 2021 Jun 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/vaxelis-epar-product-information_en.pdf"},{"key":"cit0005","unstructured":"European Medicines Agency (EMA). Hexavac - withdrawal of marketing authorisation in the European Union. 2012 [cited 2020 Oct 05]. https:\/\/www.ema.europa.eu\/en\/documents\/public-statement\/public-statement-hexavac-withdrawalmarketing-authorisation-european-union_en.pdf;"},{"key":"cit0006","unstructured":"US Food and Drug Administration. Clinical review \u2013 Vaxelis [Internet]. Silver Spring (MD): US Food and Drug Administration; [updated 2020 Oct 29; cited 2021 Jun 18]. Available from: https:\/\/www.fda.gov\/media\/119740\/download."},{"key":"cit0007","unstructured":"European Medicines Agency. Vaxelis \u2013 EPAR: public assessment report [Internet]. Amsterdam (EU): European Medicines Agency; [updated 2016 Feb 26, cited 2021 Jun 18]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/vaxelis-epar-public-assessment-report_en.pdf"},{"key":"cit0008","unstructured":"US Food and Drug Administration. Product information \u2013 package insert Vaxelis [Internet]; Silver Spring (MD): US Food and Drug Administration; [updated 2020 Oct 29, cited 2021 Jun 18]. Available from: https:\/\/www.fda.gov\/media\/119465\/download"},{"key":"cit0009","unstructured":"ClinicalTrials.gov Identifier: NCT01337167 [Internet]. Safety, tolerability, and immunogenicity of V419 given concomitantly with prevnar 13\u2122 and RotaTeq\u2122 (V419-005). [Cited 18 Jun 2021]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01337167"},{"key":"cit0010","unstructured":"ClinicalTrials.gov Identifier: NCT01340937 [Internet]. A study of V419 given concomitantly with prevnar 13\u2122 and RotaTeq\u2122 (V419-006). [Cited18 Jun 2021]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01340937."},{"key":"cit0011","unstructured":"ClinicalTrials.gov Identifier: NCT01341639 [Internet]. Safety, tolerability, and immunogenicity of V419 in healthy infants when given at 2, 3, 4 and 12 months (V419-007) [Cited18 Jun 2021]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01341639"},{"key":"cit0012","unstructured":"ClinicalTrials.gov Identifier: NCT01480258 [Internet]. Safety, tolerability, and immunogenicity of V419 in healthy infants when given at 2, 4, and 11 to 12 months (V419-008) [Cited18 Jun 2021]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01480258"},{"key":"cit0013","unstructured":"EudraVigilance. Eudravigilance data sets Vaxelis [Internet]; [updated 2021 Jun 12; cited 2021 Jun 13]. Available from: https:\/\/dap.ema.europa.eu\/analytics\/saw.dll?PortalPages"},{"key":"cit0014","unstructured":"Agenzia Italiana del Farmaco. Rapporto Vaccini 2018 [Internet]. Roma (IT): Agenzia Italiana del Farmaco; [updated 2019 Jul 30; cited 2021 Jun 18]. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/241056\/Rapporto%20Vaccini%202018.pdf"},{"key":"cit0015","unstructured":"Agenzia Italiana del Farmaco. Rapporto Vaccini 2019 [Internet]. Roma (IT): Agenzia Italiana del Farmaco; [updated 2020 Dec 17; cited 2021 Jun 18]. Available from: https:\/\/www.aifa.gov.it\/documents\/20142\/241052\/Rapporto_Vaccini_2019.pdf"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-016-0208-y"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2019.1690457"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002257"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1268920"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001405"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6905a5"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182717edf"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000437806.76221.20"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.043"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026953"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.07.007"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1107685"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1756668"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-019-0742-7"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1419070"},{"key":"cit0031","unstructured":"European Medicines Agency. Hexyon \u2013 EPAR: public assessment report [Internet]. Amsterdam (EU): Eur opean Med icines Agency; [updated 2013 Jul 12; cited 2021 Jun 18]. Avai lable from: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/hexyon-epar-public-assessment-report_en.pdf"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.06.033"},{"key":"cit0033","unstructured":"Immunization, vaccines and biologicals [Internet]. Geneva: World Health Organization; WHO recommendations for routine immunization - summary tables; 2020 Sep [cited 2021 Jun 18]. Available from: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/policies\/who-recommendations-for-routine-immunization\u2014summary-tables"},{"issue":"2","key":"cit0034","first-page":"1","volume":"60","author":"National Center for Immunization and Respiratory Diseases","year":"2011","journal-title":"MMWR Recomm Rep"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2022.2007882","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T14:17:53Z","timestamp":1646403473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2022.2007882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,27]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,4]]}},"alternative-id":["10.1080\/14740338.2022.2007882"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2022.2007882","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2021,11,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}